“Radiobiology of Proton Therapy”: Results of an international expert workshop
The physical properties of proton beams offer the potential to reduce toxicity in tumor-adjacent normal tissues. Toward this end, the number of proton radiotherapy facilities has steeply increased over the last 10–15 years to currently around 70 operational centers worldwide. However, taking full ad...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Lühr, Armin [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2018transfer abstract |
|---|
| Schlagwörter: |
|---|
| Umfang: |
12 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells - Han, Xiaobing ELSEVIER, 2021, journal of the European Society for Therapeutic Radiology and Oncology, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:128 ; year:2018 ; number:1 ; pages:56-67 ; extent:12 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.radonc.2018.05.018 |
|---|
| Katalog-ID: |
ELV044707401 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV044707401 | ||
| 003 | DE-627 | ||
| 005 | 20230626005629.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 181123s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.radonc.2018.05.018 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000656.pica |
| 035 | |a (DE-627)ELV044707401 | ||
| 035 | |a (ELSEVIER)S0167-8140(18)30277-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 570 |a 540 |q VZ |
| 100 | 1 | |a Lühr, Armin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a “Radiobiology of Proton Therapy”: Results of an international expert workshop |
| 264 | 1 | |c 2018transfer abstract | |
| 300 | |a 12 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a The physical properties of proton beams offer the potential to reduce toxicity in tumor-adjacent normal tissues. Toward this end, the number of proton radiotherapy facilities has steeply increased over the last 10–15 years to currently around 70 operational centers worldwide. However, taking full advantage of the opportunities offered by proton radiation for clinical radiotherapy requires a better understanding of the radiobiological effects of protons alone or combined with drugs or immunotherapy on normal tissues and tumors. This report summarizes the main results of the international expert workshop “Radiobiology of Proton Therapy” that was held in November 2016 in Dresden. | ||
| 520 | |a The physical properties of proton beams offer the potential to reduce toxicity in tumor-adjacent normal tissues. Toward this end, the number of proton radiotherapy facilities has steeply increased over the last 10–15 years to currently around 70 operational centers worldwide. However, taking full advantage of the opportunities offered by proton radiation for clinical radiotherapy requires a better understanding of the radiobiological effects of protons alone or combined with drugs or immunotherapy on normal tissues and tumors. This report summarizes the main results of the international expert workshop “Radiobiology of Proton Therapy” that was held in November 2016 in Dresden. | ||
| 650 | 7 | |a Radiobiology |2 Elsevier | |
| 650 | 7 | |a Trial design |2 Elsevier | |
| 650 | 7 | |a Relative biological effectiveness (RBE) |2 Elsevier | |
| 650 | 7 | |a Treatment planning |2 Elsevier | |
| 650 | 7 | |a Proton beam therapy |2 Elsevier | |
| 700 | 1 | |a von Neubeck, Cläre |4 oth | |
| 700 | 1 | |a Pawelke, Jörg |4 oth | |
| 700 | 1 | |a Seidlitz, Annekatrin |4 oth | |
| 700 | 1 | |a Peitzsch, Claudia |4 oth | |
| 700 | 1 | |a Bentzen, Søren M. |4 oth | |
| 700 | 1 | |a Bortfeld, Thomas |4 oth | |
| 700 | 1 | |a Debus, Jürgen |4 oth | |
| 700 | 1 | |a Deutsch, Eric |4 oth | |
| 700 | 1 | |a Langendijk, Johannes A. |4 oth | |
| 700 | 1 | |a Loeffler, Jay S. |4 oth | |
| 700 | 1 | |a Mohan, Radhe |4 oth | |
| 700 | 1 | |a Scholz, Michael |4 oth | |
| 700 | 1 | |a Sørensen, Brita S. |4 oth | |
| 700 | 1 | |a Weber, Damien C. |4 oth | |
| 700 | 1 | |a Baumann, Michael |4 oth | |
| 700 | 1 | |a Krause, Mechthild |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Han, Xiaobing ELSEVIER |t Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |d 2021 |d journal of the European Society for Therapeutic Radiology and Oncology |g Amsterdam [u.a.] |w (DE-627)ELV00004122X |
| 773 | 1 | 8 | |g volume:128 |g year:2018 |g number:1 |g pages:56-67 |g extent:12 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.radonc.2018.05.018 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 128 |j 2018 |e 1 |h 56-67 |g 12 | ||
| author_variant |
a l al |
|---|---|
| matchkey_str |
lhrarminvonneubeckclrepawelkejrgseidlitz:2018----:aibooyfrtnhrprslsfnnento |
| hierarchy_sort_str |
2018transfer abstract |
| publishDate |
2018 |
| allfields |
10.1016/j.radonc.2018.05.018 doi GBV00000000000656.pica (DE-627)ELV044707401 (ELSEVIER)S0167-8140(18)30277-9 DE-627 ger DE-627 rakwb eng 570 540 VZ Lühr, Armin verfasserin aut “Radiobiology of Proton Therapy”: Results of an international expert workshop 2018transfer abstract 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The physical properties of proton beams offer the potential to reduce toxicity in tumor-adjacent normal tissues. Toward this end, the number of proton radiotherapy facilities has steeply increased over the last 10–15 years to currently around 70 operational centers worldwide. However, taking full advantage of the opportunities offered by proton radiation for clinical radiotherapy requires a better understanding of the radiobiological effects of protons alone or combined with drugs or immunotherapy on normal tissues and tumors. This report summarizes the main results of the international expert workshop “Radiobiology of Proton Therapy” that was held in November 2016 in Dresden. The physical properties of proton beams offer the potential to reduce toxicity in tumor-adjacent normal tissues. Toward this end, the number of proton radiotherapy facilities has steeply increased over the last 10–15 years to currently around 70 operational centers worldwide. However, taking full advantage of the opportunities offered by proton radiation for clinical radiotherapy requires a better understanding of the radiobiological effects of protons alone or combined with drugs or immunotherapy on normal tissues and tumors. This report summarizes the main results of the international expert workshop “Radiobiology of Proton Therapy” that was held in November 2016 in Dresden. Radiobiology Elsevier Trial design Elsevier Relative biological effectiveness (RBE) Elsevier Treatment planning Elsevier Proton beam therapy Elsevier von Neubeck, Cläre oth Pawelke, Jörg oth Seidlitz, Annekatrin oth Peitzsch, Claudia oth Bentzen, Søren M. oth Bortfeld, Thomas oth Debus, Jürgen oth Deutsch, Eric oth Langendijk, Johannes A. oth Loeffler, Jay S. oth Mohan, Radhe oth Scholz, Michael oth Sørensen, Brita S. oth Weber, Damien C. oth Baumann, Michael oth Krause, Mechthild oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:128 year:2018 number:1 pages:56-67 extent:12 https://doi.org/10.1016/j.radonc.2018.05.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 128 2018 1 56-67 12 |
| spelling |
10.1016/j.radonc.2018.05.018 doi GBV00000000000656.pica (DE-627)ELV044707401 (ELSEVIER)S0167-8140(18)30277-9 DE-627 ger DE-627 rakwb eng 570 540 VZ Lühr, Armin verfasserin aut “Radiobiology of Proton Therapy”: Results of an international expert workshop 2018transfer abstract 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The physical properties of proton beams offer the potential to reduce toxicity in tumor-adjacent normal tissues. Toward this end, the number of proton radiotherapy facilities has steeply increased over the last 10–15 years to currently around 70 operational centers worldwide. However, taking full advantage of the opportunities offered by proton radiation for clinical radiotherapy requires a better understanding of the radiobiological effects of protons alone or combined with drugs or immunotherapy on normal tissues and tumors. This report summarizes the main results of the international expert workshop “Radiobiology of Proton Therapy” that was held in November 2016 in Dresden. The physical properties of proton beams offer the potential to reduce toxicity in tumor-adjacent normal tissues. Toward this end, the number of proton radiotherapy facilities has steeply increased over the last 10–15 years to currently around 70 operational centers worldwide. However, taking full advantage of the opportunities offered by proton radiation for clinical radiotherapy requires a better understanding of the radiobiological effects of protons alone or combined with drugs or immunotherapy on normal tissues and tumors. This report summarizes the main results of the international expert workshop “Radiobiology of Proton Therapy” that was held in November 2016 in Dresden. Radiobiology Elsevier Trial design Elsevier Relative biological effectiveness (RBE) Elsevier Treatment planning Elsevier Proton beam therapy Elsevier von Neubeck, Cläre oth Pawelke, Jörg oth Seidlitz, Annekatrin oth Peitzsch, Claudia oth Bentzen, Søren M. oth Bortfeld, Thomas oth Debus, Jürgen oth Deutsch, Eric oth Langendijk, Johannes A. oth Loeffler, Jay S. oth Mohan, Radhe oth Scholz, Michael oth Sørensen, Brita S. oth Weber, Damien C. oth Baumann, Michael oth Krause, Mechthild oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:128 year:2018 number:1 pages:56-67 extent:12 https://doi.org/10.1016/j.radonc.2018.05.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 128 2018 1 56-67 12 |
| allfields_unstemmed |
10.1016/j.radonc.2018.05.018 doi GBV00000000000656.pica (DE-627)ELV044707401 (ELSEVIER)S0167-8140(18)30277-9 DE-627 ger DE-627 rakwb eng 570 540 VZ Lühr, Armin verfasserin aut “Radiobiology of Proton Therapy”: Results of an international expert workshop 2018transfer abstract 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The physical properties of proton beams offer the potential to reduce toxicity in tumor-adjacent normal tissues. Toward this end, the number of proton radiotherapy facilities has steeply increased over the last 10–15 years to currently around 70 operational centers worldwide. However, taking full advantage of the opportunities offered by proton radiation for clinical radiotherapy requires a better understanding of the radiobiological effects of protons alone or combined with drugs or immunotherapy on normal tissues and tumors. This report summarizes the main results of the international expert workshop “Radiobiology of Proton Therapy” that was held in November 2016 in Dresden. The physical properties of proton beams offer the potential to reduce toxicity in tumor-adjacent normal tissues. Toward this end, the number of proton radiotherapy facilities has steeply increased over the last 10–15 years to currently around 70 operational centers worldwide. However, taking full advantage of the opportunities offered by proton radiation for clinical radiotherapy requires a better understanding of the radiobiological effects of protons alone or combined with drugs or immunotherapy on normal tissues and tumors. This report summarizes the main results of the international expert workshop “Radiobiology of Proton Therapy” that was held in November 2016 in Dresden. Radiobiology Elsevier Trial design Elsevier Relative biological effectiveness (RBE) Elsevier Treatment planning Elsevier Proton beam therapy Elsevier von Neubeck, Cläre oth Pawelke, Jörg oth Seidlitz, Annekatrin oth Peitzsch, Claudia oth Bentzen, Søren M. oth Bortfeld, Thomas oth Debus, Jürgen oth Deutsch, Eric oth Langendijk, Johannes A. oth Loeffler, Jay S. oth Mohan, Radhe oth Scholz, Michael oth Sørensen, Brita S. oth Weber, Damien C. oth Baumann, Michael oth Krause, Mechthild oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:128 year:2018 number:1 pages:56-67 extent:12 https://doi.org/10.1016/j.radonc.2018.05.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 128 2018 1 56-67 12 |
| allfieldsGer |
10.1016/j.radonc.2018.05.018 doi GBV00000000000656.pica (DE-627)ELV044707401 (ELSEVIER)S0167-8140(18)30277-9 DE-627 ger DE-627 rakwb eng 570 540 VZ Lühr, Armin verfasserin aut “Radiobiology of Proton Therapy”: Results of an international expert workshop 2018transfer abstract 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The physical properties of proton beams offer the potential to reduce toxicity in tumor-adjacent normal tissues. Toward this end, the number of proton radiotherapy facilities has steeply increased over the last 10–15 years to currently around 70 operational centers worldwide. However, taking full advantage of the opportunities offered by proton radiation for clinical radiotherapy requires a better understanding of the radiobiological effects of protons alone or combined with drugs or immunotherapy on normal tissues and tumors. This report summarizes the main results of the international expert workshop “Radiobiology of Proton Therapy” that was held in November 2016 in Dresden. The physical properties of proton beams offer the potential to reduce toxicity in tumor-adjacent normal tissues. Toward this end, the number of proton radiotherapy facilities has steeply increased over the last 10–15 years to currently around 70 operational centers worldwide. However, taking full advantage of the opportunities offered by proton radiation for clinical radiotherapy requires a better understanding of the radiobiological effects of protons alone or combined with drugs or immunotherapy on normal tissues and tumors. This report summarizes the main results of the international expert workshop “Radiobiology of Proton Therapy” that was held in November 2016 in Dresden. Radiobiology Elsevier Trial design Elsevier Relative biological effectiveness (RBE) Elsevier Treatment planning Elsevier Proton beam therapy Elsevier von Neubeck, Cläre oth Pawelke, Jörg oth Seidlitz, Annekatrin oth Peitzsch, Claudia oth Bentzen, Søren M. oth Bortfeld, Thomas oth Debus, Jürgen oth Deutsch, Eric oth Langendijk, Johannes A. oth Loeffler, Jay S. oth Mohan, Radhe oth Scholz, Michael oth Sørensen, Brita S. oth Weber, Damien C. oth Baumann, Michael oth Krause, Mechthild oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:128 year:2018 number:1 pages:56-67 extent:12 https://doi.org/10.1016/j.radonc.2018.05.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 128 2018 1 56-67 12 |
| allfieldsSound |
10.1016/j.radonc.2018.05.018 doi GBV00000000000656.pica (DE-627)ELV044707401 (ELSEVIER)S0167-8140(18)30277-9 DE-627 ger DE-627 rakwb eng 570 540 VZ Lühr, Armin verfasserin aut “Radiobiology of Proton Therapy”: Results of an international expert workshop 2018transfer abstract 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The physical properties of proton beams offer the potential to reduce toxicity in tumor-adjacent normal tissues. Toward this end, the number of proton radiotherapy facilities has steeply increased over the last 10–15 years to currently around 70 operational centers worldwide. However, taking full advantage of the opportunities offered by proton radiation for clinical radiotherapy requires a better understanding of the radiobiological effects of protons alone or combined with drugs or immunotherapy on normal tissues and tumors. This report summarizes the main results of the international expert workshop “Radiobiology of Proton Therapy” that was held in November 2016 in Dresden. The physical properties of proton beams offer the potential to reduce toxicity in tumor-adjacent normal tissues. Toward this end, the number of proton radiotherapy facilities has steeply increased over the last 10–15 years to currently around 70 operational centers worldwide. However, taking full advantage of the opportunities offered by proton radiation for clinical radiotherapy requires a better understanding of the radiobiological effects of protons alone or combined with drugs or immunotherapy on normal tissues and tumors. This report summarizes the main results of the international expert workshop “Radiobiology of Proton Therapy” that was held in November 2016 in Dresden. Radiobiology Elsevier Trial design Elsevier Relative biological effectiveness (RBE) Elsevier Treatment planning Elsevier Proton beam therapy Elsevier von Neubeck, Cläre oth Pawelke, Jörg oth Seidlitz, Annekatrin oth Peitzsch, Claudia oth Bentzen, Søren M. oth Bortfeld, Thomas oth Debus, Jürgen oth Deutsch, Eric oth Langendijk, Johannes A. oth Loeffler, Jay S. oth Mohan, Radhe oth Scholz, Michael oth Sørensen, Brita S. oth Weber, Damien C. oth Baumann, Michael oth Krause, Mechthild oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:128 year:2018 number:1 pages:56-67 extent:12 https://doi.org/10.1016/j.radonc.2018.05.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 128 2018 1 56-67 12 |
| language |
English |
| source |
Enthalten in Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells Amsterdam [u.a.] volume:128 year:2018 number:1 pages:56-67 extent:12 |
| sourceStr |
Enthalten in Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells Amsterdam [u.a.] volume:128 year:2018 number:1 pages:56-67 extent:12 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Radiobiology Trial design Relative biological effectiveness (RBE) Treatment planning Proton beam therapy |
| dewey-raw |
570 |
| isfreeaccess_bool |
false |
| container_title |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
| authorswithroles_txt_mv |
Lühr, Armin @@aut@@ von Neubeck, Cläre @@oth@@ Pawelke, Jörg @@oth@@ Seidlitz, Annekatrin @@oth@@ Peitzsch, Claudia @@oth@@ Bentzen, Søren M. @@oth@@ Bortfeld, Thomas @@oth@@ Debus, Jürgen @@oth@@ Deutsch, Eric @@oth@@ Langendijk, Johannes A. @@oth@@ Loeffler, Jay S. @@oth@@ Mohan, Radhe @@oth@@ Scholz, Michael @@oth@@ Sørensen, Brita S. @@oth@@ Weber, Damien C. @@oth@@ Baumann, Michael @@oth@@ Krause, Mechthild @@oth@@ |
| publishDateDaySort_date |
2018-01-01T00:00:00Z |
| hierarchy_top_id |
ELV00004122X |
| dewey-sort |
3570 |
| id |
ELV044707401 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV044707401</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626005629.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">181123s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.radonc.2018.05.018</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000656.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV044707401</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0167-8140(18)30277-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lühr, Armin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">“Radiobiology of Proton Therapy”: Results of an international expert workshop</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">12</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The physical properties of proton beams offer the potential to reduce toxicity in tumor-adjacent normal tissues. Toward this end, the number of proton radiotherapy facilities has steeply increased over the last 10–15 years to currently around 70 operational centers worldwide. However, taking full advantage of the opportunities offered by proton radiation for clinical radiotherapy requires a better understanding of the radiobiological effects of protons alone or combined with drugs or immunotherapy on normal tissues and tumors. This report summarizes the main results of the international expert workshop “Radiobiology of Proton Therapy” that was held in November 2016 in Dresden.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The physical properties of proton beams offer the potential to reduce toxicity in tumor-adjacent normal tissues. Toward this end, the number of proton radiotherapy facilities has steeply increased over the last 10–15 years to currently around 70 operational centers worldwide. However, taking full advantage of the opportunities offered by proton radiation for clinical radiotherapy requires a better understanding of the radiobiological effects of protons alone or combined with drugs or immunotherapy on normal tissues and tumors. This report summarizes the main results of the international expert workshop “Radiobiology of Proton Therapy” that was held in November 2016 in Dresden.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Radiobiology</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Trial design</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Relative biological effectiveness (RBE)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Treatment planning</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Proton beam therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">von Neubeck, Cläre</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pawelke, Jörg</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Seidlitz, Annekatrin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Peitzsch, Claudia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bentzen, Søren M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bortfeld, Thomas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Debus, Jürgen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Deutsch, Eric</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Langendijk, Johannes A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Loeffler, Jay S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mohan, Radhe</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Scholz, Michael</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sørensen, Brita S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Weber, Damien C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Baumann, Michael</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Krause, Mechthild</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Han, Xiaobing ELSEVIER</subfield><subfield code="t">Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells</subfield><subfield code="d">2021</subfield><subfield code="d">journal of the European Society for Therapeutic Radiology and Oncology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00004122X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:128</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:56-67</subfield><subfield code="g">extent:12</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.radonc.2018.05.018</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">128</subfield><subfield code="j">2018</subfield><subfield code="e">1</subfield><subfield code="h">56-67</subfield><subfield code="g">12</subfield></datafield></record></collection>
|
| author |
Lühr, Armin |
| spellingShingle |
Lühr, Armin ddc 570 Elsevier Radiobiology Elsevier Trial design Elsevier Relative biological effectiveness (RBE) Elsevier Treatment planning Elsevier Proton beam therapy “Radiobiology of Proton Therapy”: Results of an international expert workshop |
| authorStr |
Lühr, Armin |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV00004122X |
| format |
electronic Article |
| dewey-ones |
570 - Life sciences; biology 540 - Chemistry & allied sciences |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
570 540 VZ “Radiobiology of Proton Therapy”: Results of an international expert workshop Radiobiology Elsevier Trial design Elsevier Relative biological effectiveness (RBE) Elsevier Treatment planning Elsevier Proton beam therapy Elsevier |
| topic |
ddc 570 Elsevier Radiobiology Elsevier Trial design Elsevier Relative biological effectiveness (RBE) Elsevier Treatment planning Elsevier Proton beam therapy |
| topic_unstemmed |
ddc 570 Elsevier Radiobiology Elsevier Trial design Elsevier Relative biological effectiveness (RBE) Elsevier Treatment planning Elsevier Proton beam therapy |
| topic_browse |
ddc 570 Elsevier Radiobiology Elsevier Trial design Elsevier Relative biological effectiveness (RBE) Elsevier Treatment planning Elsevier Proton beam therapy |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
n c v nc ncv j p jp a s as c p cp s m b sm smb t b tb j d jd e d ed j a l ja jal j s l js jsl r m rm m s ms b s s bs bss d c w dc dcw m b mb m k mk |
| hierarchy_parent_title |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
| hierarchy_parent_id |
ELV00004122X |
| dewey-tens |
570 - Life sciences; biology 540 - Chemistry |
| hierarchy_top_title |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV00004122X |
| title |
“Radiobiology of Proton Therapy”: Results of an international expert workshop |
| ctrlnum |
(DE-627)ELV044707401 (ELSEVIER)S0167-8140(18)30277-9 |
| title_full |
“Radiobiology of Proton Therapy”: Results of an international expert workshop |
| author_sort |
Lühr, Armin |
| journal |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
| journalStr |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
500 - Science |
| recordtype |
marc |
| publishDateSort |
2018 |
| contenttype_str_mv |
zzz |
| container_start_page |
56 |
| author_browse |
Lühr, Armin |
| container_volume |
128 |
| physical |
12 |
| class |
570 540 VZ |
| format_se |
Elektronische Aufsätze |
| author-letter |
Lühr, Armin |
| doi_str_mv |
10.1016/j.radonc.2018.05.018 |
| dewey-full |
570 540 |
| title_sort |
“radiobiology of proton therapy”: results of an international expert workshop |
| title_auth |
“Radiobiology of Proton Therapy”: Results of an international expert workshop |
| abstract |
The physical properties of proton beams offer the potential to reduce toxicity in tumor-adjacent normal tissues. Toward this end, the number of proton radiotherapy facilities has steeply increased over the last 10–15 years to currently around 70 operational centers worldwide. However, taking full advantage of the opportunities offered by proton radiation for clinical radiotherapy requires a better understanding of the radiobiological effects of protons alone or combined with drugs or immunotherapy on normal tissues and tumors. This report summarizes the main results of the international expert workshop “Radiobiology of Proton Therapy” that was held in November 2016 in Dresden. |
| abstractGer |
The physical properties of proton beams offer the potential to reduce toxicity in tumor-adjacent normal tissues. Toward this end, the number of proton radiotherapy facilities has steeply increased over the last 10–15 years to currently around 70 operational centers worldwide. However, taking full advantage of the opportunities offered by proton radiation for clinical radiotherapy requires a better understanding of the radiobiological effects of protons alone or combined with drugs or immunotherapy on normal tissues and tumors. This report summarizes the main results of the international expert workshop “Radiobiology of Proton Therapy” that was held in November 2016 in Dresden. |
| abstract_unstemmed |
The physical properties of proton beams offer the potential to reduce toxicity in tumor-adjacent normal tissues. Toward this end, the number of proton radiotherapy facilities has steeply increased over the last 10–15 years to currently around 70 operational centers worldwide. However, taking full advantage of the opportunities offered by proton radiation for clinical radiotherapy requires a better understanding of the radiobiological effects of protons alone or combined with drugs or immunotherapy on normal tissues and tumors. This report summarizes the main results of the international expert workshop “Radiobiology of Proton Therapy” that was held in November 2016 in Dresden. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| container_issue |
1 |
| title_short |
“Radiobiology of Proton Therapy”: Results of an international expert workshop |
| url |
https://doi.org/10.1016/j.radonc.2018.05.018 |
| remote_bool |
true |
| author2 |
von Neubeck, Cläre Pawelke, Jörg Seidlitz, Annekatrin Peitzsch, Claudia Bentzen, Søren M. Bortfeld, Thomas Debus, Jürgen Deutsch, Eric Langendijk, Johannes A. Loeffler, Jay S. Mohan, Radhe Scholz, Michael Sørensen, Brita S. Weber, Damien C. Baumann, Michael Krause, Mechthild |
| author2Str |
von Neubeck, Cläre Pawelke, Jörg Seidlitz, Annekatrin Peitzsch, Claudia Bentzen, Søren M. Bortfeld, Thomas Debus, Jürgen Deutsch, Eric Langendijk, Johannes A. Loeffler, Jay S. Mohan, Radhe Scholz, Michael Sørensen, Brita S. Weber, Damien C. Baumann, Michael Krause, Mechthild |
| ppnlink |
ELV00004122X |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.radonc.2018.05.018 |
| up_date |
2024-07-06T22:12:55.581Z |
| _version_ |
1803869461500919808 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV044707401</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626005629.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">181123s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.radonc.2018.05.018</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000656.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV044707401</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0167-8140(18)30277-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lühr, Armin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">“Radiobiology of Proton Therapy”: Results of an international expert workshop</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">12</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The physical properties of proton beams offer the potential to reduce toxicity in tumor-adjacent normal tissues. Toward this end, the number of proton radiotherapy facilities has steeply increased over the last 10–15 years to currently around 70 operational centers worldwide. However, taking full advantage of the opportunities offered by proton radiation for clinical radiotherapy requires a better understanding of the radiobiological effects of protons alone or combined with drugs or immunotherapy on normal tissues and tumors. This report summarizes the main results of the international expert workshop “Radiobiology of Proton Therapy” that was held in November 2016 in Dresden.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The physical properties of proton beams offer the potential to reduce toxicity in tumor-adjacent normal tissues. Toward this end, the number of proton radiotherapy facilities has steeply increased over the last 10–15 years to currently around 70 operational centers worldwide. However, taking full advantage of the opportunities offered by proton radiation for clinical radiotherapy requires a better understanding of the radiobiological effects of protons alone or combined with drugs or immunotherapy on normal tissues and tumors. This report summarizes the main results of the international expert workshop “Radiobiology of Proton Therapy” that was held in November 2016 in Dresden.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Radiobiology</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Trial design</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Relative biological effectiveness (RBE)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Treatment planning</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Proton beam therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">von Neubeck, Cläre</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pawelke, Jörg</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Seidlitz, Annekatrin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Peitzsch, Claudia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bentzen, Søren M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bortfeld, Thomas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Debus, Jürgen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Deutsch, Eric</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Langendijk, Johannes A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Loeffler, Jay S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mohan, Radhe</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Scholz, Michael</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sørensen, Brita S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Weber, Damien C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Baumann, Michael</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Krause, Mechthild</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Han, Xiaobing ELSEVIER</subfield><subfield code="t">Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells</subfield><subfield code="d">2021</subfield><subfield code="d">journal of the European Society for Therapeutic Radiology and Oncology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00004122X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:128</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:56-67</subfield><subfield code="g">extent:12</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.radonc.2018.05.018</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">128</subfield><subfield code="j">2018</subfield><subfield code="e">1</subfield><subfield code="h">56-67</subfield><subfield code="g">12</subfield></datafield></record></collection>
|
| score |
7.401991 |